Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Pilot Study of Atibuclimab (IC14) for Treatment of ST-Elevation Myocardial Infarction

NCT06678074 is registered in ClinicalTrials.gov with Implicit Bioscience as lead sponsor.

NCT NCT06678074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06678074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Pilot Study of Atibuclimab (IC14) for Treatment of ST-Elevation Myocardial Infarction
Lead sponsor
Implicit Bioscience
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
February 6, 2025
Completion date
September 1, 2026
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stemi, stemi (st elevation mi), stemi - st elevation myocardial infarction (mi), stent implantation